BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19955348)

  • 1. Correspondence on ''the unrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production''.
    Duane DD
    J Child Neurol; 2009 Dec; 24(12):1578; author reply 1579. PubMed ID: 19955348
    [No Abstract]   [Full Text] [Related]  

  • 2. Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases.
    Aeby A; Poznanski N; Verheulpen D; Wetzburger C; Van Bogaert P
    Epilepsia; 2005 Dec; 46(12):1937-42. PubMed ID: 16393159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles.
    Genton P; Van Vleymen B
    Epileptic Disord; 2000 Jun; 2(2):99-105. PubMed ID: 10954241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamics of cognitive and emotional-volitional disorders in children and adolescents with refractory epilepsy during the treatment with levetiracetam].
    Popov IuV; Iakovleva IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):48-52. PubMed ID: 23739514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production.
    Mintz M; Legoff D; Scornaienchi J; Brown M; Levin-Allen S; Mintz P; Smith C
    J Child Neurol; 2009 Jul; 24(7):807-15. PubMed ID: 19189934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.
    Neyens LG; Alpherts WC; Aldenkamp AP
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):411-9. PubMed ID: 7624492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: an open-label multicenter study.
    Wu T; Chen CC; Chen TC; Tseng YF; Chiang CB; Hung CC; Liou HH
    Epilepsy Behav; 2009 Nov; 16(3):468-74. PubMed ID: 19783219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.
    Malykh AG; Sadaie MR
    Drugs; 2010 Feb; 70(3):287-312. PubMed ID: 20166767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of levetiracetam on spike and wave discharges in WAG/Rij rats.
    Bouwman BM; van Rijn CM
    Seizure; 2004 Dec; 13(8):591-4. PubMed ID: 15519920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical epileptiform activity in children with electrical status epilepticus during sleep: effects on cognition and behavior before and after treatment with levetiracetam.
    Bjørnæs H; Bakke KA; Larsson PG; Heminghyt E; Rytter E; Brager-Larsen LM; Eriksson AS
    Epilepsy Behav; 2013 Apr; 27(1):40-8. PubMed ID: 23376335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients.
    Cho JR; Koo DL; Joo EY; Yoon SM; Ju E; Lee J; Kim DY; Hong SB
    Clin Neurophysiol; 2012 May; 123(5):883-91. PubMed ID: 22000706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy.
    Gower AJ; Hirsch E; Boehrer A; Noyer M; Marescaux C
    Epilepsy Res; 1995 Nov; 22(3):207-13. PubMed ID: 8991787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam.
    Kasteleijn-Nolst Trenité DG; Marescaux C; Stodieck S; Edelbroek PM; Oosting J
    Epilepsy Res; 1996 Nov; 25(3):225-30. PubMed ID: 8956920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of levetiracetam in pharmacoresistant continuous spikes and waves during slow sleep.
    Capovilla G; Beccaria F; Cagdas S; Montagnini A; Segala R; Paganelli D
    Acta Neurol Scand; 2004 Sep; 110(3):144-7. PubMed ID: 15285769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spritam--a new formulation of levetiracetam for epilepsy.
    Med Lett Drugs Ther; 2016 Jun; 58(1497):78-9. PubMed ID: 27305068
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of pharmacoresistent continuous spike wave activity during slow sleep with levetiracetam.
    Hoppen T; Sandrieser T; Rister M
    Eur J Pediatr; 2003 Jan; 162(1):59-61. PubMed ID: 12607537
    [No Abstract]   [Full Text] [Related]  

  • 17. The place of levetiracetam in the treatment of epilepsy.
    Leppik IE
    Epilepsia; 2001; 42 Suppl 4():44-5. PubMed ID: 11564126
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of piracetam on the cognitive functions verified by electrophysiologic methods].
    Kondákor I
    Orv Hetil; 2002 May; 143(20):1129-33. PubMed ID: 12073660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two new drugs for epilepsy.
    Med Lett Drugs Ther; 2000 Apr; 42(1076):33-5. PubMed ID: 10803174
    [No Abstract]   [Full Text] [Related]  

  • 20. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.
    Sanchez PE; Zhu L; Verret L; Vossel KA; Orr AG; Cirrito JR; Devidze N; Ho K; Yu GQ; Palop JJ; Mucke L
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):E2895-903. PubMed ID: 22869752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.